Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS

Bedia, Jacob; Jacobs, Ian; Ryan, Andy; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Singh, Naveena; Manchanda, Ranjit; Kalsi, Jatinderpal; Dawnay, Anne; Fallowfield, Lesley; McGuire, Alistair; Campbell, Stuart; Parmar, Mahesh; Menon, Usha; Skates, Steven

Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS

journal contribution

posted on 2025-01-09, 17:44 authored by Jacob Bedia, Ian Jacobs, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Naveena Singh, Ranjit Manchanda, Jatinderpal Kalsi, Anne Dawnay, Lesley FallowfieldLesley Fallowfield, Alistair McGuire, Stuart Campbell, Mahesh Parmar, Usha Menon, Steven Skates

No description supplied

History

Publication status

Accepted

Journal

EBioMedicine

ISSN

2352-3964

Publisher

Elsevier

External DOI

https://doi.org/10.1016/j.ebiom.2024.105554

Department affiliated with

BSMS Publications
Sussex Health Outcomes Research & Education in Cancer (SHORE-C) Publications

Institution

University of Sussex

Full text available

Yes

Peer reviewed?

Yes

Usage metrics

Keywords

CA-125 antigen Ovarian epilthelial Early detection of cancer Ovarian neoplasms 1103 Clinical Sciences 1117 Public Health and Health Services 3202 Clinical sciences 4202 Epidemiology

Licence

CC BY 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS

History

Publication status

Journal

ISSN

Publisher

External DOI

Department affiliated with

Institution

Full text available

Peer reviewed?

Usage metrics

Categories

Keywords

Licence

Exports